Roche and Sheba Medical Center Partner to Improve NSCLC Diagnosis Using AI-Powered Digital Pathology
Roche and Sheba Medical Center’s ARC are collaborating to enhance NSCLC diagnosis and treatment using AI-driven digital pathology tools.
Read MorePosted by Andy Lundin | Nov 20, 2024 | Digital Pathology, Lung Cancer |
Roche and Sheba Medical Center’s ARC are collaborating to enhance NSCLC diagnosis and treatment using AI-driven digital pathology tools.
Read MorePosted by Chris Wolski | Nov 18, 2024 | Lung Cancer |
Researchers have developed a novel testing strategy for mesothelioma cancer, focusing on detecting chromosomal rearrangements in cancer DNA.
Read MorePosted by Andy Lundin | Nov 15, 2024 | Lung Cancer, Urine Analyzers |
Researchers developed a non-invasive cancer detection tool using nanowire-based miRNA extraction and AI to identify lung cancer in urine.
Read MorePosted by Andy Lundin | Nov 13, 2024 | Microscopy |
A new AI-driven tool enables neurosurgeons to detect residual brain tumor tissue in seconds, reducing the likelihood of cancer recurrence.
Read MorePosted by Andy Lundin | Nov 12, 2024 | Lung Cancer |
A blood test identifies early lung damage in cancer patients taking antibody–drug conjugates, offering an alternative to imaging scans.
Read More